Welcome to LookChem.com Sign In|Join Free

CAS

  • or

16868-13-6

Post Buying Request

16868-13-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

16868-13-6 Usage

Description

Cyclopentyl acrylate, with the molecular formula C8H12O2, is a clear, colorless liquid that belongs to the acrylate monomer family. It features a vinyl group and a carboxyl group, which make it an ideal candidate for polymerization reactions. This chemical compound is primarily utilized in the production of polymers and serves various industrial applications.

Uses

Used in Adhesives Industry:
Cyclopentyl acrylate is used as a key component in the formulation of adhesives, where it provides excellent adhesion properties. Its presence in adhesive formulations enhances the bonding strength and durability of the final product.
Used in Coatings Industry:
In the coatings industry, cyclopentyl acrylate is used as a monomer to produce high-quality coatings. It contributes to the development of coatings with improved resistance to various environmental factors, such as UV radiation, moisture, and chemicals.
Used in Resins Industry:
Cyclopentyl acrylate is also utilized in the production of specialty resins. These resins are known for their superior resistance properties, making them suitable for a wide range of applications, including automotive, construction, and electronics industries.
Used in Specialty Polymers Production:
This chemical compound is employed in the synthesis of specialty polymers for various industrial applications. The polymers derived from cyclopentyl acrylate exhibit unique properties that cater to specific needs in different industries, such as high-strength materials or heat-resistant components.
It is important to handle cyclopentyl acrylate with care and store it properly to minimize potential health and safety hazards associated with its use.

Check Digit Verification of cas no

The CAS Registry Mumber 16868-13-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,8,6 and 8 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 16868-13:
(7*1)+(6*6)+(5*8)+(4*6)+(3*8)+(2*1)+(1*3)=136
136 % 10 = 6
So 16868-13-6 is a valid CAS Registry Number.
InChI:InChI=1/C8H12O2/c1-2-8(9)10-7-5-3-4-6-7/h2,7H,1,3-6H2

16868-13-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name cyclopentyl prop-2-enoate

1.2 Other means of identification

Product number -
Other names Cyclopentyl-acrylat

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16868-13-6 SDS

16868-13-6Downstream Products

16868-13-6Relevant articles and documents

Asymmetric Diels-Alder reaction between acrylates and cyclopentadiene in the presence of chiral catalysts

Mamedov

, p. 1621 - 1625 (2008/02/07)

Asymmetric Diels-Alder reaction between cyclopentadiene and alkyl and cycloalkyl acrylates in the presence of new chiral catalysts, BBr 3?MentOEt, AlCl2OMent, BBr2OMent, and BBr(OMent)2, was studied. Optically active bicyclo[2.2.1]hept-2-ene- 5-carboxylates were synthesized. The influence of the reaction conditions on the total and optical yields and on the stereoselectivity of the adducts synthesized was examined. Nauka/Interperiodica 2006.

TREATMENT OF CNS DISORDERS USING CNS TARGET MODULATORS

-

, (2008/06/13)

The invention is directed to compositions used for treating Central Nervous System (CNS) disorders. In addition, the invention provides convenient methods of treatment of a CNS disorder. Furthermore, the invention provides methods of treating sleep disorders using compositions that remain active for a discrete period of time to reduce side effects. More specifically, the invention is directed to the compositions and use of derivatized, e.g., ester or carboxylic acid derivatized, antihistamine antagonists for the treatment of sleep disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 16868-13-6